Letter to physicians concerning the early termination of the LIBERATE clinical study
03.03.2009
In cooperation with the Agency for Medicinal Products and Medical Devices, Shering Plough d.o.o. sent a letter to physicians concerning the early termination of the LIBERATE clinical study due to a significant increase in risk of the breast cancer relapse in the group of study subjects taking the active substance tibolone in comparison with the group taking the placebo.
This clinical study has not been implemented in the Republic of Croatia.
more
